GLP-1 Medications: Market Growth, Manufacturing Opportunities, and the Future of Obesity Care
The growing adoption of GLP-1 medications is reshaping the pharmaceutical and healthcare industries. Originally developed primarily for type 2 diabetes management, GLP-1 therapies have expanded into obesity and broader cardiometabolic care, creating significant opportunities for pharmaceutical companies, contract manufacturers, healthcare providers, and other industry stakeholders.
According...
Veterinary Medicine: Market Trends, Innovations, and Opportunities in Animal Healthcare
Veterinary medicine is becoming an increasingly important part of the global healthcare and animal production ecosystem. From companion animal care to livestock health management, advances in diagnostics, vaccines, pharmaceuticals, and preventive healthcare are changing how animal diseases are managed.
The growing focus on animal welfare, disease prevention, food security, and zoonotic disease...
GLP-1 Agonist Manufacturers: Leading Companies and the Future of GLP-1 Therapies
Introduction
GLP-1 agonists have become one of the most important areas of modern metabolic medicine. Originally developed primarily for the management of type 2 diabetes, these therapies have expanded into obesity and weight-management applications, creating significant demand for innovative medicines, manufacturing capacity, and next-generation treatment options.
The market includes established...
Biosimilars Market: Affordable Biologic Therapies Accelerate Growth Through 2035
The global biosimilars market is transforming the biopharmaceutical landscape by expanding access to high-quality biologic therapies at more affordable prices. The biosimilars market size is projected to grow from USD 35.04 billion in 2025 to USD 72.29 billion by 2035, registering a CAGR of 7.5% during the forecast period. The market was valued at USD 32.75 billion in 2024.
The increasing prevalence...
Pharmaceutical Contract Manufacturing Market to Reach USD 311.95 Billion by 2030
The global Pharmaceutical Contract Manufacturing Market is projected to grow from USD 209.90 billion in 2025 to USD 311.95 billion by 2030, registering a CAGR of 8.2% during the forecast period. Growth is being driven by the increasing outsourcing of pharmaceutical production, capacity constraints in high-demand therapeutic categories such as GLP-1 drugs, continued development...
GLP-1 Agonists Market to Reach USD 170.75 Billion by 2033
Market Overview
The global GLP-1 agonists market is entering a period of rapid expansion as pharmaceutical companies, healthcare providers, and investors respond to the growing burden of obesity and type 2 diabetes. According to MarketsandMarkets, the market is projected to grow from USD 64.42 billion in 2025 to USD 170.75 billion by 2033, registering a CAGR of 13.0% during...
Pharmaceutical Excipients Market Growth, Trends, and Forecast 2030: Rising Demand for Advanced Drug Formulations
The global pharmaceutical excipients market is experiencing significant growth as pharmaceutical manufacturers increasingly focus on improving drug performance, stability, bioavailability, and patient-friendly formulations. The market is projected to reach USD 14.86 billion by 2030, growing from USD 11.03 billion in 2025 at a CAGR of 6.1% during 2025–2030. This steady expansion is driven by the...
Pharmaceutical Packaging Equipment Market Growth, Trends, and Forecast 2030: Advancing the Future of Drug Packaging
The global pharmaceutical packaging equipment market is witnessing strong expansion as pharmaceutical manufacturers increasingly prioritize safe, efficient, and technologically advanced packaging solutions. The market is projected to reach USD 14.3 billion by 2030, growing from USD 10.6 billion in 2025 at a CAGR of 6.3% during the forecast period.
The rising production of pharmaceutical products,...
Antibody Discovery Services Market Set for Strong Growth as AI and Next-Generation Biologics Transform Drug Development
The global Antibody Discovery Services Market is witnessing remarkable growth as pharmaceutical and biotechnology companies accelerate investments in biologics, precision medicine, and advanced therapeutic antibodies. Valued at USD 1.90 billion in 2025, the market is projected to reach USD 3.54 billion by 2030, growing at a CAGR of 13.3%.
The increasing development of monoclonal antibodies, bispecific...
Antibody Therapeutics Market to Reach $597.1 Billion by 2035
The global antibody therapeutics market is projected to grow from USD 311.2 billion in 2026 to USD 597.1 billion by 2035, at a CAGR of 7.5% during the forecast period. The market is experiencing strong growth due to the increasing adoption of antibody-based therapies across oncology, autoimmune diseases, inflammatory disorders, and other chronic conditions.
Download PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=178852478
Advancements...